Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Condition: Intermittent Claudication Interventions: Drug: Cilostazol 100 mg; Drug: PMR 200 mg Sponsor: Genovate Biotechnology Co., Ltd., Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2019 Category: Research Source Type: clinical trials
